Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Post by Montrose2on May 27, 2010 10:31pm
490 Views
Post# 17138798

Price Languishing

Price LanguishingIn my view there are two reasons for the current low and narrow range of stock price.

#1 - With the current aspect of consolidation "hanging in the air" but at an uncertain ratio, many people are playing the waiting game.  I take no position relative to the eventual wisdom of the consolidation move but it is a general belief that stock prices fall immediately following consolidation.  This belief is unfortunately supported by numerous incidences where such was exactly the case.   I am not selling my current position but I too would not add until consolidation is a done deal and we know exactly what ratio we are dealing with.

#2 - I suspect there are major players who want to get some sense of the actual acceptablility/marketability of this product in what for them is the "new" market of the U.S.   The effectiveness of the product is just one of the variables.  At the end of the day corporations need to know just how much penetration might be expected and at what profit.  Once that information becomes availability the reaction can range from "ho hum" to an agressive take-over.

Onward and Upward
Bullboard Posts